文献速递呼吸道感染呼吸危重症与机械通气

免疫功能受损急性呼吸衰竭患者鼻咽部病毒多重PCR检测的意义

Multiplex Polymerase Chain Reaction Assay to Detect Nasopharyngeal Viruses in Immunocompromised Patients With Acute Respiratory Failure.
PubMed 文献 · Chest · 2023-08-09

该研究为随机对照试验的事后分析,纳入32个ICU中免疫功能受损的急性呼吸衰竭患者510例,用多重PCR检测鼻咽拭子23种呼吸道病原体。

要点

  • 鼻咽部多重PCR阳性不预测免疫功能受损ARF患者的插管或死亡风险。
  • 检出流感样病毒者病毒性肺炎比例达50.0%,显著高于其他病毒和无病毒检出者。
  • 异基因造血干细胞移植受者中,检出流感样病毒与更差的复合结局相关。

核心结论

  • 在免疫功能受损的急性呼吸衰竭患者中,鼻咽部多重PCR检测结果与有创机械通气或死亡无显著关联。
  • 阳性结果患者中约三分之一最终诊断为病毒性肺炎,检出流感样病毒者约半数诊断为病毒性肺炎。

研究设计与样本

  • 共510例患者纳入分析,入组时采集鼻咽拭子,用多重PCR检测23种呼吸道病原体。
  • 急性呼吸衰竭病因由主管医师确定,并由三名对PCR结果不知情的专家复核。

主要发现

  • 510例患者中多重PCR阳性103例(20.2%),102份样本检出病毒。
  • 检出病毒中鼻病毒或肠病毒占35.5%,冠状病毒占10.9%,流感样病毒占52.7%。
  • 病毒性肺炎比例随PCR结果显著变化:流感样病毒阳性者50.0%,其他病毒阳性者14.0%,无病毒检出者3.6%(P < .001)。
  • 28天死亡率、有创机械通气或两者复合结局在PCR阳性与阴性组间无差异(54.9% vs 54.7%;P = .965)。
  • 预设亚组分析中,异基因造血干细胞移植受者检出流感样病毒与更高的28天死亡率、有创机械通气或复合结局相关。

临床怎么用

  • 鼻咽部多重PCR阳性结果不应单独用于判断急性呼吸衰竭的病因或预后。
  • 检出流感样病毒时需警惕病毒性肺炎可能,尤其在异基因造血干细胞移植受者中。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In immunocompromised patients with acute respiratory failure (ARF), the clinical significance of respiratory virus detection in the nasopharynx remains uncertain. RESEARCH QUESTION: Is viral detection in nasopharyngeal swabs associated with causes and outcomes of ARF in immunocompromised patients? STUDY DESIGN AND METHODS: This preplanned post hoc analysis of a randomized controlled trial enrolled immunocompromised patients admitted to 32 ICUs for ARF between May 2016 and December 2017. Nasopharyngeal swabs sampled at inclusion were assessed for 23 respiratory pathogens using multiplex polymerase chain reaction (PCR) assay. Causes of ARF were established by managing physicians and were reviewed by three expert investigators masked to the multiplex PCR assay results. Associations between virus detection in nasopharyngeal swabs, causes of ARF, and composite outcome of day 28 mortality, invasive mechanical ventilation (IMV), or both were assessed. RESULTS: Among the 510 sampled patients, the multiplex PCR assay results were positive in 103 patients (20.2%), and a virus was detected in 102 samples: rhinoviruses or enteroviruses in 35.5%, coronaviruses in 10.9%, and flu-like viruses (influenza virus, parainfluenza virus, respiratory syncytial virus, human metapneumovirus) in 52.7%. The cause of ARF varied significantly according to the results of the multiplex PCR assay, especially the proportion of viral pneumonia: 50.0% with flu-like viruses, 14.0% with other viruses, and 3.6% when no virus was detected (P < .001). No difference was found in the composite outcome of day 28 mortality, IMV, or both according to positive assay findings (54.9% vs 54.7%; P = .965). In a pre-established subgroup analysis, flu-like virus detection was associated with a higher rate of day 28 mortality, IMV, or both among recipients of allogeneic hematopoietic stem cell transplantation compared with those without detected virus. INTERPRETATION: In immunocompromised patients with ARF, the results of nasopharyngeal multiplex PCR assays are not associated with IMV or mortality. A final diagnosis of viral pneumonia is retained in one-third of patients with positive assay results and in one-half of the patients with a flu-like virus.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Maillard A, Le Goff J, Barry M, et al. Multiplex Polymerase Chain Reaction Assay to Detect Nasopharyngeal Viruses in Immunocompromised Patients With Acute Respiratory Failure. Chest. 2023. PMID: 37567412. doi:10.1016/j.chest.2023.07.4222

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。